{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:51:49Z","timestamp":1791312709491,"version":"4.3.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatitis B virus (HBV) infection is the major cause of inflammatory liver disease, of which the clinical recovery and effective anti-viral therapy is associated with the sustained viral control of effector T cells. In humans, chronic HBV infection often shows weak or absent virus-specific T-cell reactivity, which is described as the \u2018exhaustion\u2019 state characterized by poor effector cytotoxic activity, impaired cytokine production and sustained expression of multiple inhibitory receptors, such as programmed cell death-1 (PD-1), lymphocyte activation gene-3, cytotoxic T lymphocyte-associated antigen-4 and CD244. As both CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells participate in the immune responses against chronic hepatitis virus through distinct manners, compelling evidences have been proposed, which restore the anti-viral function of these exhausted T cells by blocking those inhibitory receptors with its ligand and will pave the way for the development of more effective immunotherapeutic and prophylactic strategies for the treatment of chronic infectious diseases. A large number of studies have stated the essentiality of T-cell exhaustion in virus-infected diseases, such as LCMV, hepatitis C virus (HCV), human immunodeficiency virus infections and cancers. Besides, the functional restoration of HCV- and HIV-specific CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells by PD-1 blockade has already been repeatedly verified, and also for the immunological control of tumors in humans, blocking the PD-1 pathway could be a major immunotherapeutic strategy. Although the specific molecular pathways of T-cell exhaustion remain ambiguous, several transcriptional pathways have been implicated in T-cell exhaustion recently; among them Blimp-1, T-bet and NFAT2 were able to regulate exhausted T cells during chronic viral infection, suggesting a distinct lineage fate for this sub-population of T cells. This paper summarizes the current literature relevant to T-cell exhaustion in patients with HBV-related chronic hepatitis, the options for identifying new potential therapeutic targets to treat HBV infection and highlights priorities for further study.\n                  <\/jats:p>","DOI":"10.1038\/cddis.2015.42","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T09:45:18Z","timestamp":1426758318000},"page":"e1694-e1694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":357,"title":["T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance"],"prefix":"10.1038","volume":"6","author":[{"given":"B","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"issue":"1","key":"BFcddis201542_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12016-014-8465-4","volume":"50","author":"Xuefen Li","year":"2014","unstructured":"Li X, Liu X, Tian L, Chen Y . Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections. Clin Rev Allergy Immunol 2014; e-pub ahead of print 6 December 2014; doi:10.1007\/s12016-014-8465-4.","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"BFcddis201542_CR2","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/JVI.00867-09","volume":"83","author":"S Asabe","year":"2009","unstructured":"Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 2009; 83: 9652\u20139662.","journal-title":"J Virol"},{"key":"BFcddis201542_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1746.2011.06940.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang JY, Wang LF, Wang FS . Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol 2012; 27: 223\u2013230.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"BFcddis201542_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/liv.12749","volume":"35","author":"C Ferrari","year":"2015","unstructured":"Ferrari C . HBV and the immune response. Liver Int 2015; 35 (Suppl 1): 121\u2013128.","journal-title":"Liver Int"},{"key":"BFcddis201542_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4049\/jimmunol.0902761","volume":"184","author":"S Phillips","year":"2010","unstructured":"Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV . CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 2010; 184: 287\u2013295.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/gut.2008.163600","volume":"58","author":"P Fisicaro","year":"2009","unstructured":"Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009; 58: 974\u2013982.","journal-title":"Gut"},{"key":"BFcddis201542_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","volume":"87","author":"A Bertoletti","year":"2006","unstructured":"Bertoletti A, Gehring AJ . The immune response during hepatitis B virus infection. J Gen Virol 2006; 87: 1439\u20131449.","journal-title":"J Gen Virol"},{"key":"BFcddis201542_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ . T cell exhaustion. Nat Immunol 2011; 12: 492\u2013499.","journal-title":"Nat Immunol"},{"key":"BFcddis201542_CR9","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","volume":"191","author":"MK Maini","year":"2000","unstructured":"Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS . The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191: 1269\u20131280.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR10","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI33402","volume":"118","author":"AR Lopes","year":"2008","unstructured":"Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008; 118: 1835\u20131845.","journal-title":"J Clin Invest"},{"key":"BFcddis201542_CR11","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007; 81: 4215\u20134225.","journal-title":"J Virol"},{"key":"BFcddis201542_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","volume":"129","author":"JS Yi","year":"2010","unstructured":"Yi JS, Cox MA, Zajac AJ . T-cell exhaustion: characteristics, causes and conversion. Immunology 2010; 129: 474\u2013481.","journal-title":"Immunology"},{"key":"BFcddis201542_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.coi.2010.02.005","volume":"22","author":"PS Kim","year":"2010","unstructured":"Kim PS, Ahmed R . Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 2010; 22: 223\u2013230.","journal-title":"Curr Opin Immunol"},{"key":"BFcddis201542_CR14","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood-2008-09-179697","volume":"114","author":"S Mumprecht","year":"2009","unstructured":"Mumprecht S, Sch\u00fcrch C, Schwaller J, Solenthaler M, Ochsenbein AF . Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood 2009; 114: 1528\u20131536.","journal-title":"Blood"},{"key":"BFcddis201542_CR15","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","volume":"114","author":"M Ahmadzadeh","year":"2009","unstructured":"Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 2009; 114: 1537\u20131544.","journal-title":"Blood"},{"key":"BFcddis201542_CR16","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.4049\/jimmunol.0803245","volume":"182","author":"J Fourcade","year":"2009","unstructured":"Fourcade J, Kudela P, Sun Z, Shen H, Land SR, Lenzner D et al. PD-1 Is a Regulator of NY-ESO-1-Specific CD8(+) T Cell Expansion in Melanoma Patients. J Immunol 2009; 182: 5240\u20135249.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR17","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","volume":"28","author":"JR Brahmer","year":"2010","unstructured":"Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010; 28: 3167\u20133175.","journal-title":"J Clin Oncol"},{"key":"BFcddis201542_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439: 682\u2013687.","journal-title":"Nature"},{"key":"BFcddis201542_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1128\/JVI.80.1.270-280.2006","volume":"80","author":"D Homann","year":"2006","unstructured":"Homann D, Dummer W, Wolfe T, Rodrigo E, Theofilopoulos AN, Oldstone MB et al. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol 2006; 80: 270\u2013280.","journal-title":"J Virol"},{"key":"BFcddis201542_CR20","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog 2009; 5: e1000313.","journal-title":"PLoS Pathog"},{"key":"BFcddis201542_CR21","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.4049\/jimmunol.180.8.5439","volume":"180","author":"V Cecchinato","year":"2008","unstructured":"Cecchinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, Tsai WP et al. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 2008; 180: 5439\u20135447.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature07662","volume":"458","author":"V Velu","year":"2009","unstructured":"Velu V, Titanji K, Zhu B, Husain S, Pladevega A, Lai L et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009; 458: 206\u2013210.","journal-title":"Nature"},{"key":"BFcddis201542_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ni.2046","volume":"12","author":"C Kao","year":"2011","unstructured":"Kao C, Oestreich KJ, Paley MA, Crawford A, Angelosanto JM, Ali MA et al. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat Immunol 2011; 12: 663\u2013671.","journal-title":"Nat Immunol"},{"key":"BFcddis201542_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford A, Angelosanto JM, Kao C, Doering TA, Odorizzi PM, Barnett BE et al. Molecular and transcriptional basis of CD4(+) T cell dysfunction during chronic infection. Immunity 2014; 40: 289\u2013302.","journal-title":"Immunity"},{"key":"BFcddis201542_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB . Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013; 13: 227\u2013242.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis201542_CR26","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.23936","volume":"52","author":"B Raziorrouh","year":"2010","unstructured":"Raziorrouh B, Schraut W, Gerlach T, Nowack D, Gr\u00fcner NH, Ulsenheimer A et al. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 2010; 52: 1934\u20131947.","journal-title":"Hepatology"},{"key":"BFcddis201542_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009; 10: 29\u201337.","journal-title":"Nat Immunol"},{"key":"BFcddis201542_CR28","doi-asserted-by":"publisher","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","volume":"6","author":"B Bengsch","year":"2010","unstructured":"Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010; 6: e1000947.","journal-title":"PLoS Pathog"},{"key":"BFcddis201542_CR29","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.180.3.933","volume":"180","author":"A Bertoletti","year":"1994","unstructured":"Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994; 180: 933\u2013943.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1182\/blood-2010-12-328070","volume":"118","author":"F Porichis","year":"2011","unstructured":"Porichis F, Kwon DS, Zupkosky J, Tighe DP, McMullen A, Brockman MA et al. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade. Blood 2011; 118: 965\u2013974.","journal-title":"Blood"},{"key":"BFcddis201542_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri3169","volume":"12","author":"U Protzer","year":"2012","unstructured":"Protzer U, Maini MK, Knolle PA . Living in the liver: hepatic infections. Nat Rev Immunol 2012; 12: 201\u2013213.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis201542_CR32","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1073\/pnas.0307252101","volume":"101","author":"YE Latchman","year":"2004","unstructured":"Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A 2004; 101: 10691\u201310696.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcddis201542_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","volume":"27","author":"T Okazaki","year":"2006","unstructured":"Okazaki T, Honjo T . The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006; 27: 195\u2013201.","journal-title":"Trends Immunol"},{"key":"BFcddis201542_CR34","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","volume":"61","author":"B Bengsch","year":"2014","unstructured":"Bengsch B, Martin B, Thimme R . Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol 2014; 61: 1212\u20131219.","journal-title":"J Hepatol"},{"key":"BFcddis201542_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","volume":"138","author":"P Fisicaro","year":"2010","unstructured":"Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010; 138: 682\u2013693.","journal-title":"Gastroenterology"},{"key":"BFcddis201542_CR36","doi-asserted-by":"publisher","first-page":"e1003208","DOI":"10.1371\/journal.ppat.1003208","volume":"9","author":"A Schurich","year":"2013","unstructured":"Schurich A, Pallett LJ, Lubowiecki M, Singh HD, Gill US, Kennedy PT et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog 2013; 9: e1003208.","journal-title":"PLoS Pathog"},{"key":"BFcddis201542_CR37","doi-asserted-by":"publisher","first-page":"13825","DOI":"10.1073\/pnas.202398599","volume":"99","author":"PL Yang","year":"2002","unstructured":"Yang PL, Althage A, Chung J, Chisari FV . Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 2002; 99: 13825\u201313830.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcddis201542_CR38","doi-asserted-by":"publisher","first-page":"e39179","DOI":"10.1371\/journal.pone.0039179","volume":"7","author":"HT Tzeng","year":"2012","unstructured":"Tzeng HT, Tsai HF, Liao HJ, Lin YJ, Chen L, Chen PJ et al. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One 2012; 7: e39179.","journal-title":"PLoS One"},{"key":"BFcddis201542_CR39","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1084\/jem.20131333","volume":"211","author":"PD Kurktschiev","year":"2014","unstructured":"Kurktschiev PD, Raziorrouh B, Schraut W, Backmund M, W\u00e4chtler M, Wendtner CM et al. Dysfunctional CD8(+) T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med 2014; 211: 2047\u20132059.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR40","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1084\/jem.183.6.2541","volume":"183","author":"TL Walunas","year":"1996","unstructured":"Walunas TL, Bakker CY, Bluestone JA . CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541\u20132550.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR41","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","volume":"183","author":"MF Krummel","year":"1996","unstructured":"Krummel MF, Allison JP . CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183: 2533\u20132540.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1084\/jem.188.1.205","volume":"188","author":"F Fallarino","year":"1998","unstructured":"Fallarino F, Fields PE, Gajewski TF . B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J Exp Med 1998; 188: 205\u2013210.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ni.1835","volume":"11","author":"W Ise","year":"2010","unstructured":"Ise W, Kohyama M, Nutsch KM, Lee HM, Suri A, Unanue ER et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol 2010; 11: 129\u2013135.","journal-title":"Nat Immunol"},{"key":"BFcddis201542_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-065X.2008.00649.x","volume":"224","author":"KS Peggs","year":"2008","unstructured":"Peggs KS, Quezada SA, Allison JP . Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev 2008; 224: 141\u2013165.","journal-title":"Immunol Rev"},{"key":"BFcddis201542_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.0141-9838.2004.00679.x","volume":"26","author":"SE Graefe","year":"2004","unstructured":"Graefe SE, Jacobs T, W\u00e4chter U, Br\u00f6ker BM, Fleischer B . CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection. Parasite Immunol 2004; 26: 19\u201328.","journal-title":"Parasite Immunol"},{"key":"BFcddis201542_CR46","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/eji.200324021","volume":"34","author":"S Zubairi","year":"2004","unstructured":"Zubairi S, Sanos SL, Hill S, Kaye PM . Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. Eur J Immunol 2004; 34: 1433\u20131440.","journal-title":"Eur J Immunol"},{"key":"BFcddis201542_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/cmi.2009.17","volume":"6","author":"Y Yu","year":"2009","unstructured":"Yu Y, Wu H, Tang Z, Zang G . CTLA4 silencing with siRNA promotes deviation of Th1\/Th2 in chronic hepatitis B patients. Cell Mol Immunol 2009; 6: 123\u2013127.","journal-title":"Cell Mol Immunol"},{"key":"BFcddis201542_CR48","doi-asserted-by":"publisher","first-page":"11258","DOI":"10.1128\/JVI.78.20.11258-11262.2004","volume":"78","author":"CL Thio","year":"2004","unstructured":"Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D et al. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol 2004; 78: 11258\u201311262.","journal-title":"J Virol"},{"key":"BFcddis201542_CR49","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.24249","volume":"53","author":"A Schurich","year":"2011","unstructured":"Schurich A, Khanna P, Lopes AR, Han KJ, Peppa D, Micco L et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494\u20131503.","journal-title":"Hepatology"},{"key":"BFcddis201542_CR50","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.1131078","volume":"313","author":"H Schneider","year":"2006","unstructured":"Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, Brewer JM et al. Reversal of the TCR stop signal by CTLA-4. Science 2006; 313: 1972\u20131975.","journal-title":"Science"},{"key":"BFcddis201542_CR51","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.4049\/jimmunol.171.11.6251","volume":"171","author":"T Keler","year":"2003","unstructured":"Keler T, Halk E, Vitale L, O'Neill T, Blanset D, Lee S et al. Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques. J Immunol 2003; 171: 6251\u20136259.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhep.2013.02.022","volume":"59","author":"B Sangro","year":"2013","unstructured":"Sangro B, Gomez-Martin C, de la Mata M, I\u00f1arrairaegui M, Garralda E, Barrera P et al. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. J Hepatol 2013; 59: 81\u201388.","journal-title":"J Hepatol"},{"key":"BFcddis201542_CR53","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1158\/1078-0432.CCR-09-2033","volume":"16","author":"JM Kirkwood","year":"2010","unstructured":"Kirkwood JM, Lorigan P, Hersey P, Hauschild A, Robert C, McDermott D et al. Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma. Clin Cancer Res 2010; 16: 1042\u20131048.","journal-title":"Clin Cancer Res"},{"key":"BFcddis201542_CR54","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1200\/JCO.2008.19.2435","volume":"27","author":"LH Camacho","year":"2009","unstructured":"Camacho LH, Antonia S, Sosman J, Kirkwood JM, Gajewski TF, Redman B et al. Phase I\/II trial of tremelimumab in patients with metastatic melanoma. J Clin Oncol 2009; 27: 1075\u20131081.","journal-title":"J Clin Oncol"},{"key":"BFcddis201542_CR55","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2010.28.3994","volume":"28","author":"KY Chung","year":"2010","unstructured":"Chung KY, Gore I, Fong L, Venook A, Beck SB, Dorazio P et al. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. J Clin Oncol 2010; 28: 3485\u20133490.","journal-title":"J Clin Oncol"},{"key":"BFcddis201542_CR56","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711\u2013723.","journal-title":"N Engl J Med"},{"key":"BFcddis201542_CR57","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.4049\/jimmunol.0803771","volume":"182","author":"DE Kaufmann","year":"2009","unstructured":"Kaufmann DE, Walker BD . PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009; 182: 5891\u20135897.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR58","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ni1515","volume":"8","author":"DE Kaufmann","year":"2007","unstructured":"Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007; 8: 1246\u20131254.","journal-title":"Nat Immunol"},{"key":"BFcddis201542_CR59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","volume":"31","author":"H Shin","year":"2009","unstructured":"Shin H, Blackburn SD, Intlekofer AM, Kao C, Angelosanto JM, Reiner SL et al. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 2009; 31: 309\u2013320.","journal-title":"Immunity"},{"key":"BFcddis201542_CR60","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6: 1245\u20131252.","journal-title":"Nat Immunol"},{"key":"BFcddis201542_CR61","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.1128\/JVI.00639-09","volume":"83","author":"L Golden-Mason","year":"2009","unstructured":"Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ et al. Negative Immune Regulator Tim-3 is overexpressed on T Cells in Hepatitis C Virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T Cells. J Virol 2009; 83: 9122\u20139130.","journal-title":"J Virol"},{"key":"BFcddis201542_CR62","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20081398","volume":"205","author":"RB Jones","year":"2008","unstructured":"Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008; 205: 2763\u20132779.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR63","doi-asserted-by":"publisher","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","volume":"7","author":"G Nebbia","year":"2012","unstructured":"Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y et al. Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 2012; 7: e47648.","journal-title":"PLoS One"},{"key":"BFcddis201542_CR64","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","volume":"52","author":"Y Ju","year":"2010","unstructured":"Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010; 52: 322\u2013329.","journal-title":"J Hepatol"},{"key":"BFcddis201542_CR65","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1172\/JCI119429","volume":"99","author":"J Wada","year":"1997","unstructured":"Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS . Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 1997; 99: 2452\u20132461.","journal-title":"J Clin Invest"},{"key":"BFcddis201542_CR66","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.25777","volume":"56","author":"H Li","year":"2012","unstructured":"Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X et al. Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2012; 56: 1342\u20131351.","journal-title":"Hepatology"},{"key":"BFcddis201542_CR67","doi-asserted-by":"publisher","first-page":"e9504","DOI":"10.1371\/journal.pone.0009504","volume":"5","author":"JA Mengshol","year":"2010","unstructured":"Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R et al. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One 2010; 5: e9504.","journal-title":"PLoS One"},{"key":"BFcddis201542_CR68","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.4049\/jimmunol.0803673","volume":"182","author":"S Sehrawat","year":"2009","unstructured":"Sehrawat S, Suryawanshi A, Hirashima M, Rouse BT . Role of Tim-3\/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol 2009; 182: 3191\u20133201.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell R et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68\u201376.","journal-title":"J Virol"},{"key":"BFcddis201542_CR70","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1084\/jem.20072076","volume":"205","author":"A Das","year":"2008","unstructured":"Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008; 205: 2111\u20132124.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR71","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1073\/pnas.0502393102","volume":"102","author":"SC Zimmerli","year":"2005","unstructured":"Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G . HIV-1-specific IFN-gamma\/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 2005; 102: 7239\u20137244.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcddis201542_CR72","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1369-5274(00)00109-0","volume":"3","author":"A Bertoletti","year":"2000","unstructured":"Bertoletti A, Maini MK . Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol 2000; 3: 387\u2013392.","journal-title":"Curr Opin Microbiol"},{"key":"BFcddis201542_CR73","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1074-7613(03)00301-7","volume":"19","author":"S Maeda","year":"2003","unstructured":"Maeda S, Chang L, Li ZW, Luo JL, Leffert H, Karin M . IKK beta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNF alpha. Immunity 2003; 19: 725\u2013737.","journal-title":"Immunity"},{"key":"BFcddis201542_CR74","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.1073\/pnas.94.16.8744","volume":"94","author":"F Su","year":"1997","unstructured":"Su F, Schneider RJ . Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad sci U S A 1997; 94: 8744\u20138749.","journal-title":"Proc Natl Acad sci U S A"},{"key":"BFcddis201542_CR75","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/sji.12099","volume":"78","author":"L Li","year":"2013","unstructured":"Li L, Liu M, Cheng LW, Gao XY, Fu JJ, Kong G et al. HBcAg-specific IL-21-producing CD4+ T cells are associated with relative viral control in patients with chronic hepatitis B. Scand J Immunol 2013; 78: 439\u2013446.","journal-title":"Scand J Immunol"},{"key":"BFcddis201542_CR76","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.0913498107","volume":"107","author":"PL Yang","year":"2010","unstructured":"Yang PL, Althage A, Chung J, Maier H, Wieland S, Isogawa M et al. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 2010; 107: 798\u2013802.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcddis201542_CR77","doi-asserted-by":"publisher","first-page":"e86348","DOI":"10.1371\/journal.pone.0086348","volume":"9","author":"T Trautmann","year":"2014","unstructured":"Trautmann T, Kozik JH, Carambia A, Richter K, Lischke T, Schwinqe D et al. CD4+T-cell help is required for Effective CD8+T cell-Mediated resolution of acute viral hepatitis in mice. PLoS One 2014; 9: e86348.","journal-title":"PLoS One"},{"key":"BFcddis201542_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","volume":"25","author":"MA Williams","year":"2007","unstructured":"Williams MA, Bevan MJ . Effector and memory CTL differentiation. Annu Rev Immunol 2007; 25: 171\u2013192.","journal-title":"Annu Rev Immunol"},{"key":"BFcddis201542_CR79","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04651","volume":"440","author":"F Castellino","year":"2006","unstructured":"Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN . Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 2006; 440: 890\u2013895.","journal-title":"Nature"},{"key":"BFcddis201542_CR80","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04790","volume":"441","author":"MA Williams","year":"2006","unstructured":"Williams MA, Tyznik AJ, Bevan MJ . Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006; 441: 890\u2013893.","journal-title":"Nature"},{"key":"BFcddis201542_CR81","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nature08511","volume":"462","author":"Y Nakanishi","year":"2009","unstructured":"Nakanishi Y, Lu B, Gerard C, Iwasaki A . CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009; 462: 510\u2013513.","journal-title":"Nature"},{"key":"BFcddis201542_CR82","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/jhep.2003.50194","volume":"37","author":"A Ulsenheimer","year":"2003","unstructured":"Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003; 37: 1189\u20131198.","journal-title":"Hepatology"},{"key":"BFcddis201542_CR83","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.2871","volume":"18","author":"M Rangachari","year":"2012","unstructured":"Rangachari M, Zhu C, Sakuishi K, Xiao S, Karman J, Chen A et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med 2012; 18: 1394\u20131400.","journal-title":"Nat Med"},{"key":"BFcddis201542_CR84","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.4049\/jimmunol.1101165","volume":"189","author":"P Antoine","year":"2012","unstructured":"Antoine P, Olislagers V, Huygens A, Lecomte S, Liesnard C, Donner C et al. Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection. J Immunol 2012; 189: 2665\u20132672.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR85","doi-asserted-by":"publisher","first-page":"e105703","DOI":"10.1371\/journal.pone.0105703","volume":"9","author":"B Raziorrouh","year":"2014","unstructured":"Raziorrouh B, Heeq M, Kurktschiev P, Schraut W, Zachoval R, Wendtner C et al. Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. PLoS One 2014; 9: e105703.","journal-title":"PLoS One"},{"key":"BFcddis201542_CR86","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1053\/j.gastro.2011.07.004","volume":"141","author":"B Raziorrouh","year":"2011","unstructured":"Raziorrouh B, Ulsenheimer A, Schraut W, Heep M, Kurktschiev P, Zachoval R et al. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. Gastroenterology 2011; 141: 1422\u20131431.","journal-title":"Gastroenterology"},{"key":"BFcddis201542_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1084\/jem.20100388","volume":"209","author":"J Schulze Zur Wiesch","year":"2012","unstructured":"Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, Streeck H et al. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 2012; 209: 61\u201375.","journal-title":"J Exp Med"},{"key":"BFcddis201542_CR88","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.4049\/jimmunol.1000156","volume":"185","author":"A Kassu","year":"2010","unstructured":"Kassu A, Marcus RA, D'Souza MB, Kelly-McKnight EA, Golden-Mason L, Akkina R et al. Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection. J Immunol 2010; 185: 3007\u20133018.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR89","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/nar\/gku1272","volume":"43","author":"KN Rybakova","year":"2015","unstructured":"Rybakova KN, Tomaszewska A, van Mourik S, Blom J, Westerhoff HV, Carlberg C et al. Tracing the molecular basis of transcriptional dynamics in noisy data by using an experiment-based mathematical model. Nucleic Acids Res 2015; 43: 153\u2013161.","journal-title":"Nucleic Acids Res"},{"key":"BFcddis201542_CR90","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010; 52: 999\u20131007.","journal-title":"Hepatology"},{"key":"BFcddis201542_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.dnarep.2014.03.024","volume":"19","author":"L Xu","year":"2014","unstructured":"Xu L, Da L, Plouffe SW, Chong J, Kool E, Wang D . Molecular basis of transcriptional fidelity and DNA lesion-induced transcriptional mutagenesis. DNA Repair (Amst) 2014; 19: 71\u201383.","journal-title":"DNA Repair (Amst)"},{"key":"BFcddis201542_CR92","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.biochi.2014.01.011","volume":"101","author":"BJ Schuchardt","year":"2014","unstructured":"Schuchardt BJ, Bhat V, Mikles DC, McDonald CB, Sudol M, Farooq A . Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase. Biochimie 2014; 101: 192\u2013202.","journal-title":"Biochimie"},{"key":"BFcddis201542_CR93","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1128\/JVI.02202-06","volume":"81","author":"N Alatrakchi","year":"2007","unstructured":"Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ . Hepatitis C virus (HCV)-specific CD8(+) cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 2007; 81: 5882\u20135892.","journal-title":"J Virol"},{"key":"BFcddis201542_CR94","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/hep.20649","volume":"41","author":"JN Stoop","year":"2005","unstructured":"Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771\u2013778.","journal-title":"Hepatology"},{"key":"BFcddis201542_CR95","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/intimm\/dxl130","volume":"19","author":"G Yang","year":"2007","unstructured":"Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B et al. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007; 19: 133\u2013140.","journal-title":"Int Immunol"},{"key":"BFcddis201542_CR96","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","volume":"79","author":"O Franzese","year":"2005","unstructured":"Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005; 79: 3322\u20133328.","journal-title":"J Virol"},{"key":"BFcddis201542_CR97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clim.2008.07.029","volume":"129","author":"JN Stoop","year":"2008","unstructured":"Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 2008; 129: 419\u2013427.","journal-title":"Clin Immunol"},{"key":"BFcddis201542_CR98","doi-asserted-by":"publisher","first-page":"e49389","DOI":"10.1371\/journal.pone.0049389","volume":"7","author":"MA Claassen","year":"2012","unstructured":"Claassen MA, de Knegt RJ, Turgut D, Groothuismink ZM, Janssen HL, Boonstra A . Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha\/ribavirin therapy. PLoS One 2012; 7: e49389.","journal-title":"PLoS One"},{"key":"BFcddis201542_CR99","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","volume":"178","author":"H Maier","year":"2007","unstructured":"Maier H, Isogawa M, Freeman GJ, Chisari FV . PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 2007; 178: 2714\u20132720.","journal-title":"J Immunol"},{"key":"BFcddis201542_CR100","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley MA, Kroy DC, Odorizzi PM, Johnnidis JB, Dolfi DV, Barnett BE et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 2012; 338: 1220\u20131225.","journal-title":"Science"},{"key":"BFcddis201542_CR101","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27: 670\u2013684.","journal-title":"Immunity"},{"key":"BFcddis201542_CR102","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/COH.0000000000000091","volume":"9","author":"MH Collins","year":"2014","unstructured":"Collins MH, Henderson AJ . Transcriptional regulation and T cell exhaustion. Curr Opin HIV AIDS 2014; 9: 459\u2013463.","journal-title":"Curr Opin HIV AIDS"},{"key":"BFcddis201542_CR103","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2009.10.008","volume":"31","author":"H Kwon","year":"2009","unstructured":"Kwon H, Thierry-Mieg D, Thierry-Mieg J, Kim HP, Oh J, Tunyaplin C et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009; 31: 941\u2013952.","journal-title":"Immunity"},{"key":"BFcddis201542_CR104","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2217\/imt.11.117","volume":"3","author":"JJ Subleski","year":"2011","unstructured":"Subleski JJ, Jiang Q, Weiss JM, Wiltrout RH . The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy 2011; 3: 1167\u20131184.","journal-title":"Immunotherapy"},{"key":"BFcddis201542_CR105","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.it.2006.05.003","volume":"27","author":"A La Cava","year":"2006","unstructured":"La Cava A, Van Kaer L . Fu-Dong-Shi. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 2006; 27: 322\u2013327.","journal-title":"Trends Immunol"},{"key":"BFcddis201542_CR106","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1038\/srep06359","volume":"4","author":"CF Chen","year":"2014","unstructured":"Chen CF, Feng X, Liao HY, Jin WJ, Zhang J, Wang Y et al. Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection. Sci Rep 2014; 4: 6359.","journal-title":"Sci Rep"},{"key":"BFcddis201542_CR107","doi-asserted-by":"publisher","first-page":"e105703","DOI":"10.1371\/journal.pone.0105703","volume":"9","author":"B Raziorrouh","year":"2014","unstructured":"Raziorrouh B, Heeg M, Kurktschiev P, Schraut W, Zachoval R1, Wendtner C et al. Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. PLoS One 2014; 9: e105703.","journal-title":"PLoS One"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis201542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201542","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2015.42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:15:34Z","timestamp":1672895734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":107,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["BFcddis201542"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2015.42","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]},"assertion":[{"value":"14 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}